Reducing New-Onset Atrial Fibrillation After Coronary Artery Bypass Graft Surgery

Area of Science:

• Cardiology
• Cardiac Surgery
• Pharmacology

Background:

• Postoperative atrial fibrillation (POAF) is the most frequent dysrhythmia following coronary artery bypass graft (CABG) surgery, affecting 10-40% of patients.
• POAF can lead to serious complications including hemodynamic instability, heart failure, stroke, prolonged hospital stays, increased readmissions, and higher mortality rates.
• Risk factors for POAF include hypertension, diabetes, chronic kidney disease, and obesity, highlighting the need for effective prevention strategies.

Purpose of the Study:

• To develop and implement an evidence-based protocol for postoperative atrial fibrillation prophylaxis using amiodarone.
• To evaluate the effectiveness of amiodarone prophylaxis in reducing the incidence of POAF in patients undergoing CABG surgery.

Main Methods:

• A quality improvement project was conducted at a tertiary care center in southeastern Michigan.
• An evidence-based protocol utilizing amiodarone for POAF prophylaxis was developed and implemented.
• The protocol was applied to patients with no prior history of atrial fibrillation undergoing CABG surgery.

Main Results:

• The implementation of the amiodarone prophylaxis protocol showed a reduction in the incidence of postoperative atrial fibrillation.
• This suggests that amiodarone can be an effective prophylactic measure for POAF in the studied patient population.

Conclusions:

• Amiodarone prophylaxis is a viable strategy to decrease the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery.
• Implementing evidence-based protocols for POAF prevention can improve patient outcomes, reduce hospital costs, and enhance the overall quality of care.